Examining Patient Cases in Pulmonary Arterial Hypertension

Program Type



1.25 Contact Hour(s)

Release Date

Wednesday, July 13, 2016

Offline Date:

Saturday, July 13, 2019

ACPE Expiration Date

Saturday, July 13, 2019

Target Audience




  • Overview

    This activity is intended to educate pharmacists on therapeutic options for the treatment of pulmonary hypertension.   Participants will have a thorough understanding of the epidemiology, clinical symptoms, pathophysiology, and treatment goals of pulmonary arterial hypertension.  Diagnostic methods will be reviewed.  The presentation will detail pharmacologic treatment options for PAH including targeted pathways, routes of administration, indication, dosing, benefits, and potential adverse effects.  Patient cases will be presented throughout the session to enable participants to apply medical knowledge.


    This recorded activity is a based on a live program that was offered on May 12, 2016 in Woburn, MA.



    Bryan Cook, PharmD, BCPS; Clinical Pharmacy Specialist - Cardiology/Coronary Care Unit

    Brigham & Women's Hospital, Boston, MA does not have any relevant financial relationships with any commercial interests.


    American Health Resources assesses conflict of interest with its instructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity.


    Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  American Health Resources does not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.



    Homestudy PDF:   1- PAH CE Slides-WEB -FINAL- HANDOUTS.pdf

    Financial Support By

  • Pharmacist

    Summarize the pathophysiology and classifications of pulmonary arterial hypertension.
    Evaluate therapeutic options in the treatment of PAH based on safety and efficacy.
    Apply guidelines to patient cases to determine best course of treatment.

  • Activity Type


    Universal Activity Number

    Pharmacist 0280-0000-16-052-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

  • Faculty

    Bryan Cook, PharmD, BCPS
    Clinical Pharmacy Specialist - Cardiology/Coronary Care Unit, Brigham & Women's Hospital


843 488 5550 Office

843 488 5554 Fax Email Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.